Beta
ManageSearchChatDiscover
76610

Evaluation of Testing of Serum Survivin and Alpha Fetoprotein in Patients with Hepatocellular Carcinoma and Hepatitis C Viral Infection

Article

Last updated: 22 Jan 2023

OverviewSimilar Items

Subjects

-

Tags

-

Abstract

Survivin is specific antiapoptotic gene product expressed in a variety of human neoplasmswhoseoverexpression might assist in early diagnosis and as a prognostic marker. The aim was to evaluate the plasma levels of survivin and alpha fetoprotein in patients with chronic hepatitis C viral infection (HCV) with and without hepatocellular carcinoma (HCC). 70 subjects were divided into: a control group (Group I) ( 20 healthy volunteers ) and two patients groups: Group II, HCV group (20 patients); and Group III, HCC with HCV(30 patients). Thorough physical examination, ultrasonography of the abdomen, laboratory investigations (liver profile, anti-HCV antibodies, hepatitis B surface antigen, Alpha fetoprotein (chemiluminometry) and Survivin (ELISA)) were performed. There was a significant increase in survivin level in HCV patients (Group II) when compared to the control group (p=0.039), along with a significant increase in AFP in Groups II and III when compared to Group I (P<0.001 for both). AFP also distinguished between the two HCV groups. The best generated cut off value for AFP was 10.9 ng/ml and for survivin 13.7 pg/ml. Serum survivin diagnostic sensitivity was 53.3%, diagnostic specificity 62.5% and efficiency 58.6%, in contrast to 100%, 92.5% and 95.7%, respectively, for AFPWhile survivin showed significant increase in the HCV group, its diagnostic performance was lower and it proved to be less reliable as a tumor marker for HCC than did AFP.

DOI

10.21608/rjab.2019.76610

Keywords

apoptosis, survivin, Hepatocellular carcinoma, Alpha fetoprotein

Authors

First Name

Usama

Last Name

Shaalan

MiddleName

-

Affiliation

Molecular diagnostics and Therapeutics department, Genetic Engineering and Biotechnology Research Institute (GEBRI), University of Sadat City, Egypt

Email

-

City

-

Orcid

-

First Name

Ahmed

Last Name

Sharawy

MiddleName

-

Affiliation

Clinical Pathology Department, National Liver Institute, Menofia University

Email

-

City

-

Orcid

-

First Name

Mohamad

Last Name

Othman

MiddleName

-

Affiliation

Molecular diagnostics and Therapeutics department, Genetic Engineering and Biotechnology Research Institute (GEBRI), University of Sadat City, Egypt

Email

-

City

-

Orcid

-

First Name

Hani

Last Name

Elharoun

MiddleName

-

Affiliation

Clinical Pathology Department, National Liver Institute, Menofia University

Email

ramohani@hotmail.com

City

-

Orcid

-

Volume

5

Article Issue

1

Related Issue

11477

Issue Date

2019-06-01

Receive Date

2020-03-09

Publish Date

2019-06-01

Page Start

15

Page End

22

Print ISSN

2356-9433

Online ISSN

2682-3470

Article File

RJAB_Volume 5_Issue 1_Pages 15-22.pdf

PDF . 680.9kB

Link

https://rjab.journals.ekb.eg/article_76610.html

Detail API

https://rjab.journals.ekb.eg/service?article_code=76610

Order

2

Type

Original Article

Type Code

890

Publication Type

Journal

Publication Title

Research Journal of Applied Biotechnology

Publication Link

https://rjab.journals.ekb.eg/

MainTitle

-

Details

Type

Article

Created At

22 Jan 2023